[1] |
PAN BT, JOHNSTONE RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor[J]. Cell, 1983, 33(3): 967-978. DOI: 10.1016/0092-8674(83)90040-5.
|
[2] |
SIMONS M, RAPOSO G. Exosomes--vesicular carriers for intercellular communication[J]. Curr Opin Cell Biol, 2009, 21(4): 575-581. DOI: 10.1016/j.ceb.2009.03.007.
|
[3] |
AMBROS V. The functions of animal microRNAs[J]. Nature, 2004, 431(7006): 350-355. DOI: 10.1038/nature02871.
|
[4] |
LIU R, MA X, CHEN L, et al. MicroRNA-15b suppresses Th17 differentiation and is associated with pathogenesis of multiple sclerosis by targeting O-GlcNAc transferase[J]. J Immunol, 2017, 198(7): 2626-2639. DOI: 10.4049/jimmunol.1601727.
|
[5] |
LAKSHMI S, HUGHES TA, PRIYA S. Exosomes and exosomal RNAs in breast cancer: A status update[J]. Eur J Cancer, 2021, 144: 252-268. DOI: 10.1016/j.ejca.2020.11.033.
|
[6] |
HENNING RJ. Cardiovascular exosomes and MicroRNAs in cardiovascular physiology and pathophysiology[J]. J Cardiovasc Transl Res, 2021, 14(2): 195-212. DOI: 10.1007/s12265-020-10040-5.
|
[7] |
THÉRY C, ZITVOGEL L, AMIGORENA S. Exosomes: composition, biogenesis and function[J]. Nat Rev Immunol, 2002, 2(8): 569-579. DOI: 10.1038/nri855.
|
[8] |
KALLURI R, LEBLEU VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478): eaau6977. DOI: 10.1126/science.aau6977.
|
[9] |
LI X, LI C, ZHANG L, et al. The significance of exosomes in the development and treatment of hepatocellular carcinoma[J]. Mol Cancer, 2020, 19(1): 1. DOI: 10.1186/s12943-019-1085-0.
|
[10] |
LI C, ZHOU T, CHEN J, et al. The role of Exosomal miRNAs in cancer[J]. J Transl Med, 2022, 20(1): 6. DOI: 10.1186/s12967-021-03215-4.
|
[11] |
CHAHAR HS, BAO X, CASOLA A. Exosomes and their role in the life cycle and pathogenesis of RNA viruses[J]. Viruses, 2015, 7(6): 3204-3225. DOI: 10.3390/v7062770.
|
[12] |
JIANG W, MA P, DENG L, et al. Hepatitis A virus structural protein pX interacts with ALIX and promotes the secretion of virions and foreign proteins through exosome-like vesicles[J]. J Extracell Vesicles, 2020, 9(1): 1716513. DOI: 10.1080/20013078.2020.1716513.
|
[13] |
ZHANG GL, LI YX, ZHENG SQ, et al. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210[J]. Antiviral Res, 2010, 88(2): 169-175. DOI: 10.1016/j.antiviral.2010.08.008.
|
[14] |
YANG X, LI H, SUN H, et al. Hepatitis B virus-encoded MicroRNA controls viral replication[J]. J Virol, 2017, 91(10): e01919-16. DOI: 10.1128/JVI.01919-16.
|
[15] |
RAMAKRISHNAIAH V, THUMANN C, FOFANA I, et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells[J]. Proc Natl Acad Sci U S A, 2013, 110(32): 13109-13113. DOI: 10.1073/pnas.1221899110.
|
[16] |
BUKONG TN, MOMEN-HERAVI F, KODYS K, et al. Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90[J]. PLoS Pathog, 2014, 10(10): e1004424. DOI: 10.1371/journal.ppat.1004424.
|
[17] |
THAKURI B KC, ZHANG J, ZHAO J, et al. HCV-associated exosomes upregulate RUNXOR and RUNX1 expressions to promote MDSC expansion and suppressive functions through STAT3-miR124 axis[J]. Cells, 2020, 9(12): 2715. DOI: 10.3390/cells9122715.
|
[18] |
ZHOU Y, WANG X, SUN L, et al. Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes[J]. FASEB J, 2016, 30(12): 4132-4140. DOI: 10.1096/fj.201600696R.
|
[19] |
CHEN L, CHEN R, KEMPER S, et al. Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: Role of exosomes in horizontal transfer of Twist1[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 309(6): G491-G499. DOI: 10.1152/ajpgi.00140.2015.
|
[20] |
CHEN L, CHEN R, VELAZQUEZ VM, et al. Fibrogenic signaling is suppressed in hepatic stellate cells through targeting of connective tissue growth factor (CCN2) by cellular or exosomal microRNA-199a-5p[J]. Am J Pathol, 2016, 186(11): 2921-2933. DOI: 10.1016/j.ajpath.2016.07.011.
|
[21] |
LEE YS, KIM SY, KO E, et al. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells[J]. Sci Rep, 2017, 7(1): 3710. DOI: 10.1038/s41598-017-03389-2.
|
[22] |
QU Y, ZHANG Q, CAI X, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation[J]. J Cell Mol Med, 2017, 21(10): 2491-2502. DOI: 10.1111/jcmm.13170.
|
[23] |
SUN C, SHI C, DUAN X, et al. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4[J]. Bioengineered, 2022, 13(3): 5915-5927. DOI: 10.1080/21655979.2021.2023799.
|
[24] |
KIM JH, LEE CH, LEE SW. Exosomal transmission of MicroRNA from HCV replicating cells stimulates transdifferentiation in hepatic stellate cells[J]. Mol Ther Nucleic Acids, 2019, 14: 483-497. DOI: 10.1016/j.omtn.2019.01.006.
|
[25] |
CHALLAGUNDLA KB, WISE PM, Neviani P, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy[J]. J Natl Cancer Inst, 2015, 107(7): djv135. DOI: 10.1093/jnci/djv135.
|
[26] |
BOVY N, BLOMME B, FRÈRES P, et al. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer[J]. Oncotarget, 2015, 6(12): 10253-10266. DOI: 10.18632/oncotarget.3520.
|
[27] |
ZHANG X, CHEN F, HUANG P, et al. Exosome-depleted MiR-148a-3p derived from hepatic stellate cells promotes tumor progression via ITGA5/PI3K/Akt axis in hepatocellular carcinoma[J]. Int J Biol Sci, 2022, 18(6): 2249-2260. DOI: 10.7150/ijbs.66184.
|
[28] |
CHEN C, LUO F, LIU X, et al. NF-kB-regulated exosomal miR-155 promotes the inflammation associated with arsenite carcinogenesis[J]. Cancer Lett, 2017, 388: 21-33. DOI: 10.1016/j.canlet.2016.11.027.
|
[29] |
AFFO S, YU LX, SCHWABE RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer[J]. Annu Rev Pathol, 2017, 12: 153-186. DOI: 10.1146/annurev-pathol-052016-100322.
|
[30] |
ZHOU Y, REN H, DAI B, et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts[J]. J Exp Clin Cancer Res, 2018, 37(1): 324. DOI: 10.1186/s13046-018-0965-2.
|
[31] |
FANG T, LV H, LV G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J]. Nat Commun, 2018, 9(1): 191. DOI: 10.1038/s41467-017-02583-0.
|
[32] |
YANG F, NING Z, MA L, et al. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts[J]. Mol Cancer, 2017, 16(1): 148. DOI: 10.1186/s12943-017-0718-4.
|
[33] |
YUGAWA K, YOSHIZUMI T, MANO Y, et al. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p[J]. Eur J Surg Oncol, 2021, 47(2): 384-393. DOI: 10.1016/j.ejso.2020.08.002.
|
[34] |
XIE F, YUAN Y, XIE L, et al. miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma[J]. Onco Targets Ther, 2017, 10: 885-894. DOI: 10.2147/OTT.S122992.
|
[35] |
ZHANG Z, LI X, SUN W, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis[J]. Cancer Lett, 2017, 397: 33-42. DOI: 10.1016/j.canlet.2017.03.004.
|
[36] |
LIN Q, ZHOU CR, BAI MJ, et al. Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis[J]. Am J Transl Res, 2020, 12(3): 1080-1095.
|
[37] |
LIN XJ, FANG JH, YANG XJ, et al. Hepatocellular carcinoma cell-secreted exosomal microRNA-210 promotes angiogenesis in vitro and in vivo[J]. Mol Ther Nucleic Acids, 2018, 11: 243-252. DOI: 10.1016/j.omtn.2018.02.014.
|
[38] |
FANG JH, ZHANG ZJ, SHANG LR, et al. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins[J]. Hepatology, 2018, 68(4): 1459-1475. DOI: 10.1002/hep.29920.
|